Cutler Group’s HOOKIPA Pharma HOOK Stock Holding History

Cutler Group’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-370	Closed	-$3K	–	4721
2022 Q3	$3K	Sell	370 -110	-23%	-$1.69K	﹤0.01%	3961
2022 Q2	$5K	Hold	480	–	–	﹤0.01%	3708
2022 Q1	$4K	Buy	+480	New	+$8.6K	﹤0.01%	4272

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's HOOK Position: Q4 2022 in Review

Cutler Group sold out of HOOKIPA Pharma (HOOK) in Q4 2022, closing a stake of 370 shares — an estimated $4K sold.

Cutler Group first reported a position in HOOK in Q1 2022 and held it in 3 quarters. The position peaked at $32K in Q1 2022. 55 funds tracked by Wall St. Rank hold HOOK as of Q4 2022.

Cutler Group reported no remaining HOOKIPA Pharma position as of Q4 2022 after selling out during the quarter.
Cutler Group sold 370 HOOKIPA Pharma shares in Q4 2022, an estimated $4K.
Cutler Group first reported a position in HOOKIPA Pharma in Q1 2022 and held it in 3 quarters.
Cutler Group's HOOKIPA Pharma position peaked at $32K in Q1 2022.
55 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.